Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients by F. V. Moiseenko, M. A. Krasavina, I. R. Agranov, E. V. Artemieva, A. P. Oganesian, A. S. Gabina, M. L. Makarkina, E. O. Elsakova, V. A. Henshtein, N. M. Volkov, V. V. Egorenkov, V. M. Moiseenko, M. Yu. Fedyanin, G. S. Kopeina, B. Zhivotovsky, A. V. Zamaraev

Get full text